Balyasny Asset Management LLC Bausch Health Companies Inc. Call Options Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $5.72 Million - $8.8 Million	1,000,000 New	1,000,000 $8 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $1.66 Million - $5.55 Million	235,000 Added 167.86%	375,000 $3.14 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $22.1 Million - $27.8 Million	-960,000 Reduced 87.27%	140,000 $3.87 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $13.4 Million - $18.1 Million	900,000 Added 450.0%	1,100,000 $17.1 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $2.66 Million - $4.1 Million	200,000 New	200,000 $3.66 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.